Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernie J A Penning-van Beest

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Pharmacy World & Science : PWS|April 25, 2007
Quantity and quality of potential drug interactions with coumarin anticoagulants in the NetherlandsFernie J A Penning-van Beest, Jeroen Koerselman, Ron M C Herings
Clinical Drug Investigation|July 5, 2008
Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control studyFernie J A Penning-van Beest, Bruce H R Wolffenbuttel, Ron M C Herings
Clinical Epidemiology|May 20, 2020
Existing Data Sources for Clinical Epidemiology: The PHARMO Database NetworkJosephina G Kuiper, Marina Bakker, Fernie J A Penning-van Beest, et al.
Current Medical Research and Opinion|October 17, 2008
Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures Willemijn M Meijer, Fernie J A Penning-van Beest, Melvin Olson, et al.
Current Medical Research and Opinion|April 3, 2008
Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosisFernie J A Penning-van Beest, Joëlle A Erkens, M Olson, et al.
Clinical Therapeutics|May 9, 2006
Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosisFernie J A Penning-van Beest, Wim G Goettsch, Joëlle A Erkens, et al.
Drug Safety|May 23, 2009
Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the NetherlandsMichiel W van der Linden, Fernie J A Penning-van Beest, Tamar Nijsten, et al.
Pharmacoepidemiology and Drug Safety|September 28, 2017
Thrombotic risk minimization for Diane-35 and genericsIrene D Bezemer, Elisabeth Smits, Fernie J A Penning-van Beest, et al.
Human Psychopharmacology|June 15, 2016
Post authorization safety study comparing quetiapine to risperidone and olanzapineEdith M Heintjes, Jetty A Overbeek, Fernie J A Penning-van Beest, et al.
Current Medical Research and Opinion|September 12, 2009
Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort studyEdith M Heintjes, Fernie J A Penning-van Beest, Saga Johansson, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Pharmacy World & Science : PWS|April 25, 2007
Quantity and quality of potential drug interactions with coumarin anticoagulants in the NetherlandsFernie J A Penning-van Beest, Jeroen Koerselman, Ron M C Herings
Clinical Drug Investigation|July 5, 2008
Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control studyFernie J A Penning-van Beest, Bruce H R Wolffenbuttel, Ron M C Herings
Clinical Epidemiology|May 20, 2020
Existing Data Sources for Clinical Epidemiology: The PHARMO Database NetworkJosephina G Kuiper, Marina Bakker, Fernie J A Penning-van Beest, et al.
Current Medical Research and Opinion|October 17, 2008
Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures Willemijn M Meijer, Fernie J A Penning-van Beest, Melvin Olson, et al.
Current Medical Research and Opinion|April 3, 2008
Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosisFernie J A Penning-van Beest, Joëlle A Erkens, M Olson, et al.
Clinical Therapeutics|May 9, 2006
Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosisFernie J A Penning-van Beest, Wim G Goettsch, Joëlle A Erkens, et al.
Drug Safety|May 23, 2009
Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the NetherlandsMichiel W van der Linden, Fernie J A Penning-van Beest, Tamar Nijsten, et al.
Pharmacoepidemiology and Drug Safety|September 28, 2017
Thrombotic risk minimization for Diane-35 and genericsIrene D Bezemer, Elisabeth Smits, Fernie J A Penning-van Beest, et al.
Human Psychopharmacology|June 15, 2016
Post authorization safety study comparing quetiapine to risperidone and olanzapineEdith M Heintjes, Jetty A Overbeek, Fernie J A Penning-van Beest, et al.
Current Medical Research and Opinion|September 12, 2009
Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort studyEdith M Heintjes, Fernie J A Penning-van Beest, Saga Johansson, et al.
Pageof 5